Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02487797 · ClinicalTrials.gov registry record · Phase 4
Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,003
- Enrollment target
NCT02487797 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 1,003 participants.
The verdict
NCT02487797, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,003 participants
- Enrollment target
Study Summary
Oxytocin is a medication that is often used to strengthen contractions to overcome delayed labor progress. The primary aim of this study is to determine whether receiving a higher dose of oxytocin lowers the chance of needing a cesarean section when compared to a lower dose of oxytocin. Other aims include examining the relationship between dose of oxytocin regimen and length of labor, postpartum hemorrhage, intrauterine infection, umbilical cord gas, neonatal Apgar score \<5 at 5 minutes, and need for neonatal intensive care.
Interventions
- DRUG Oxytocin
- OTHER Sodium Chloride 0.9%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,003 participants |
| Start Date | 2015-09-28 |
| Est. Completion | 2020-09-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02487797
The ClinicalTrials.gov registry entry for NCT02487797 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,003 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxytocin is the first listed.
NCT02487797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02487797 about?
NCT02487797 is a clinical study titled "Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation". Oxytocin is a medication that is often used to strengthen contractions to overcome delayed labor progress. The primary aim of this study is to determine whether receiving a higher dose of oxytocin lowers the chance of needing a cesarean section when compared to a lower dose of oxytocin. Other aims i...
What is the current status of trial NCT02487797?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,003 participants. The study started on 2015-09-28. Estimated completion is 2020-09-28.
What interventions are being tested in trial NCT02487797?
The interventions under investigation include: Oxytocin (DRUG), Sodium Chloride 0.9% (OTHER).
Who is sponsoring clinical trial NCT02487797?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.